Evidence map›Paper›PMID 35976179›Full record

ArticleJMIR formative research2022

Collaborative Challenges of Multi-Cohort Projects in Pharmacogenetics-Why Time Is Essential for Meaningful Collaborations.

Filippo Franchini, Katharina Kusejko, Catia Marzolini, Christoph Tellenbach, Simona Rossi, Susanne Stampf, Michael Koller, Jivko Stoyanov, Burkhard Möller, Alexander Benedikt Leichtle

Abstract read
In one paragraph

Article in JMIR formative research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Filippo FranchiniUniversity Institute of Clinical Chemistry, Inselspital - Bern University Hospital, University of Bern, Bern, Switzerland.ORCID https://orcid.org/0000-0002-6069-6682
Katharina KusejkoDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zürich, Switzerland.ORCID https://orcid.org/0000-0002-4638-1940
Catia MarzoliniDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland.ORCID https://orcid.org/0000-0002-2312-7050
Christoph TellenbachSwiss Clinical Quality Management in Rheumatic Diseases, Zürich, Switzerland.ORCID https://orcid.org/0000-0002-9088-2187
Simona RossiSwiss Transplant Cohort Study, Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland.ORCID https://orcid.org/0000-0002-2733-5615
Susanne StampfSwiss Transplant Cohort Study, Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland.ORCID https://orcid.org/0000-0003-3399-5078
Michael KollerSwiss Transplant Cohort Study, Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland.ORCID https://orcid.org/0000-0001-5252-6010
Jivko StoyanovSwiss Paraplegic Research, Nottwil, Switzerland.ORCID https://orcid.org/0000-0001-6842-6284
Burkhard MöllerUniversity Clinics of Rheumatology and Immunology, Inselspital - Bern University Hospital and University of Bern, Bern, Switzerland.ORCID https://orcid.org/0000-0001-8769-6167
Alexander Benedikt LeichtleUniversity Institute of Clinical Chemistry, Inselspital - Bern University Hospital, University of Bern, Bern, Switzerland.ORCID https://orcid.org/0000-0002-6528-9904

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multi-cohort projects in medicine provide an opportunity to investigate scientific questions beyond the boundaries of a single institution and endeavor to increase the sample size for obtaining more reliable results. However, the complications of these kinds of collaborations arise during management, with many administrative hurdles. Hands-on approaches and lessons learned from previous collaborations provide solutions for optimized collaboration models. Here, we use our experience in running PGX-link, a Swiss multi-cohort project, to show the strategy we used to tackle different challenges from project setup to obtaining the relevant permits, including ethics approval. We set PGX-link in an international context because our struggles were similar to those encountered during the SYNCHROS (SYNergies for Cohorts in Health: integrating the ROle of all Stakeholders) project. We provide ad hoc solutions for cohorts, general project management strategies, and suggestions for unified protocols between cohorts that would ease current management hurdles. Project managers are not necessarily familiar with medical projects, and even if they are, they are not aware of the intricacies behind decision-making and consequently, of the time needed to set up multi-cohort collaborations. This paper is meant to be a brief overview of what we experienced with our multi-cohort project and provides the necessary practices for future managers.

Indexed as

ethical, legal, and social implicationsethicsguidelinesmulticentricpersonalized medicinestudy

Identifiers

PMID35976179
PMCPMC9562084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.